A randomized trial of antithrombin concentrate for treatment of heparin resistance

Annals of Thoracic Surgery

Volumn 70, Issue 3, 2000, Pages 873-877

  Williams, Mathew R ^a   D'Ambra, Alyssa B ^a   Beck, James R ^a   Spanier, Talia B ^a   Morales, David L S ^a   Helman, David N ^a   Oz, Mehmet C ^a  

^a College of Physicians and Surgeons ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTITHROMBIN; ANTITHROMBIN III; FRESH FROZEN PLASMA; HEPARIN;

ADULT; AGED; ANTICOAGULATION; ANTITHROMBIN DEFICIENCY; ARTICLE; BLOOD CLOTTING TIME; CARDIOPULMONARY BYPASS; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG RESISTANCE; DRUG RESPONSE; FEMALE; HEPARINIZATION; HUMAN; MALE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL;

ANTITHROMBINS; BLOOD COAGULATION TESTS; CARDIOPULMONARY BYPASS; DRUG RESISTANCE; FEMALE; HEPARIN; HUMANS; MALE; MIDDLE AGED; THROMBIN;

EID: 0033807417     PISSN: 00034975     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0003-4975(00)01550-2     Document Type: Article

References (15)

1. Heparin resistance after preoperative heparin therapy or intraaortic balloon pumping
2. Antithrombin III during cardiac surgery: Effect on response of activated clotting time to heparin and relationship to markers of hemostatic activation
3. Indicators of fibrinolysis during cardiopulmonary bypass after exogenous antithrombin-III administration for acquired antithrombin III deficiency
4. Antithrombin concentrates in heparin-resistant cardiopulmonary bypass patients
5. The anticoagulant activation of antithrombin by heparin
6. Uses of antithrombin III concentrate in congenital and acquired deficiency states
7. Elimination of intravenously administered radiolabeled antithrombin III and heparin in humans
8. Diminished anticoagulant response to heparin in patients undergoing coronary artery bypass grafting
9. Heparin resistance during cardiopulmonary bypass
10. Antithrombin-III. Plasma activity during and after prolonged use of heparin in unstable angina
11. Heparin-induced decrease in circulation antithrombin-III
12. The influence of preoperative anticoagulation on heparin response during cardiopulmonary bypass
13. Intravenous nitroglycerin-induced heparin resistance: A qualitative anti-thrombin III abnormality
14. Heparin and antithrombin III levels during cardiopulmonary bypass: Correlation with subclinical plasma coagulation
15. Heparin binding proteins: Contribution to heparin rebound after cardiopulmonary bypass